Association between IL-15 and insulin plasmatic concentrations in patients with pulmonary tuberculosis and type 2 diabetes
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Tuberculosis
- Vol. 111, 114-120
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Respiratory Diseases
- CONACyT (389902)
This publication has 46 references indexed in Scilit:
- Preliminary analysis of immune activation in early onset type 2 diabetesInternational Journal of Circumpolar Health, 2013
- Analysis of Immune Responses against a Wide Range of Mycobacterium tuberculosis Antigens in Patients with Active Pulmonary TuberculosisClinical and Vaccine Immunology, 2012
- Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary TuberculosisPulmonary Medicine, 2012
- Childhood Tuberculosis in Household Contacts of Newly Diagnosed TB PatientsPLOS ONE, 2012
- Interleukin‐15 treatment improves glucose homeostasis and insulin sensitivity in obese miceDiabetes, Obesity and Metabolism, 2011
- Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinantsInternational Journal of Epidemiology, 2011
- Oversecretion of interleukin-15 from skeletal muscle reduces adiposityAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Tuberculosis in Poorly Controlled Type 2 Diabetes: Altered Cytokine Expression in Peripheral White Blood CellsClinical Infectious Diseases, 2008
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLOS Medicine, 2006
- The significance of glucose intolerance in pulmonary tuberculosisTubercle, 1990